Author Correction: IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity

Affiliations

• ¹ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
• ² Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
• ³ Center for Advanced Innate Cell Therapy, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
• ⁴ Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Boston, USA.
• ⁵ Harvard Medical School, Boston, USA.
• ⁶ Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
• ⁷ Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA.
• ⁸ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. gdotti@med.unc.edu.
• ⁹ Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA. gdotti@med.unc.edu.